Literature DB >> 3002898

Large hepatitis B surface antigen polypeptides of Dane particles with the receptor for polymerized human serum albumin.

H Ohnuma, K Takahashi, S Kishimoto, A Machida, M Imai, S Mishiro, S Usuda, K Oda, T Nakamura, Y Miyakawa.   

Abstract

Large hepatitis B surface antigen polypeptides with apparent molecular sizes of 39,000 and 43,000 daltons (P39 and P43) were liberated from a purified preparation of Dane particles of subtype adr. They were tested for reactivity with monoclonal antibodies raised against three synthetic oligopeptides representing fundamental sequences of the pre-S region in deoxyribonucleic acid of hepatitis B virus (subtype adr), as well as with monoclonal antibody against the major surface antigen polypeptide (P22) coded for by the S gene. Both P39 and its glycosylated form P43 bound to all four monoclonal antibodies, thereby indicating that they were coded for by the sequence of 1200 nucleotides, from the second ATG codon in the pre-S region to the stop codon of the S gene. Both P39 and P43 bound to polymerized human and chimpanzee albumins, but not to polymerized albumin from species without susceptibility to hepatitis B virus. Due to their presence in Dane particles and the expression of a polyalbumin receptor, the immune responses against P39 and P43 may have significance in infection with hepatitis B virus and its immunoprophylaxis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3002898     DOI: 10.1016/0016-5085(86)91125-x

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  7 in total

1.  Antibodies to glutaraldehyde-polymerized human albumin (anti-pHSA) in viral hepatitis.

Authors:  D E Sansonno; P Detomaso; G Leone; G Bufano; R Rizzi; O G Manghisi
Journal:  Dig Dis Sci       Date:  1989-09       Impact factor: 3.199

2.  Changes of pre-S1 and pre-S2 antigens in sera of patients with hepatitis B virus infection.

Authors:  Y Iwasaki; K Matsuura; T Tsuji
Journal:  Gastroenterol Jpn       Date:  1990-08

3.  Efficient inhibition of hepatitis B virus replication by hepatitis delta virus ribozymes delivered by targeting retrovirus.

Authors:  Chuan-Xi Wang; Yan-Qin Lu; Peng Qi; Long-Hua Chen; Jin-Xiang Han
Journal:  Virol J       Date:  2010-03-17       Impact factor: 4.099

4.  Clinical significance of low or negative titer of antibody to hepatitis B core antigen during the course of chronic hepatitis B virus infection in adolescents.

Authors:  K Matsuura; K Tobe; Y Iwasaki; H Ikeda; K Takahashi; T Tsuji
Journal:  Gastroenterol Jpn       Date:  1993-02

5.  The preS1 antigen of hepatitis B virus is highly immunogenic at the T cell level in man.

Authors:  C Ferrari; A Penna; A Bertoletti; A Cavalli; A Valli; C Schianchi; F Fiaccadori
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

6.  Translation products of pre-S(1), pre-S(2) regions and the S gene of hepatitis B virus: susceptibility of their antigenic activities to treatment with heat, urea, formalin or pepsin.

Authors:  H Ohnuma; A Machida; E Takai; F Tsuda; H Miyamoto; T Tanaka; K Oda; S Usuda; T Nakamura; Y Miyakawa
Journal:  Clin Exp Immunol       Date:  1986-12       Impact factor: 4.330

7.  HD-03/ES: A Herbal Medicine Inhibits Hepatitis B Surface Antigen Secretion in Transfected Human Hepatocarcinoma PLC/PRF/5 Cells.

Authors:  Sandeep R Varma; R Sundaram; S Gopumadhavan; Satyakumar Vidyashankar; Pralhad S Patki
Journal:  Hepat Res Treat       Date:  2013-04-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.